Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
24.20
-0.54 (-2.18%)
At close: May 12, 2026
SHA:688739 Market Cap
SHA:688739 has a market cap or net worth of 9.95 billion as of May 12, 2026. Its market cap has decreased by -1.92% in one year.
Market Cap
9.95B
Enterprise Value
4.87B
Revenue
1.31B
Ranking
n/a
PE Ratio
169.57
Stock Price
24.20
Market Cap Chart
Since October 28, 2021, SHA:688739's market cap has decreased from 33.32B to 9.95B, a decrease of -70.13%. That is a compound annual growth rate of -23.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 10.17B | -3.96% |
| Dec 31, 2025 | 10.59B | -0.17% |
| Dec 31, 2024 | 10.61B | -21.62% |
| Dec 29, 2023 | 13.54B | 6.87% |
| Dec 30, 2022 | 12.67B | -60.04% |
| Dec 31, 2021 | 31.70B | -4.84% |
| Oct 28, 2021 | 33.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Easton Biopharmaceuticals | 10.99B |
| HitGen | 10.78B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.15B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 10.04B |
| Beijing Hotgen Biotech | 9.94B |
| Jiangxi Fushine Pharmaceutical | 9.90B |
| Youcare Pharmaceutical Group | 9.56B |
| Daan Gene | 9.32B |